Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Bangkok Dusit Medical Services PCL 3-Year ROIIC %?
Bangkok Dusit Medical Services PCLBDULF 68 3-Year ROIIC % is 12.83 as of Dec. 2025, which is 92% above its 10-year median of 6.67. GuruFocus rates BDULF with a GF Score™ of 68/100 and a GF Value™ of $0.97 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 617 Healthcare Providers & Services companies, Bangkok Dusit Medical Services PCL ranks better than 66.61% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Bangkok Dusit Medical Services PCL's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 12.83%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
BDULF's 3-Year ROIIC % is ranked better than 66.61% of 617
companies
in the Healthcare Providers & Services industry
Industry Median: 3.46
vs BDULF: 12.83
Bangkok Dusit Medical Services PCL (OTCPK:BDULF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Bangkok Dusit Medical Services PCL 3-Year ROIIC % Related Terms
Bangkok Dusit Medical Services PCL 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Dusit Medical Services PCL 3-Year ROIIC % Chart
For the Medical Care Facilities subindustry, Bangkok Dusit Medical Services PCL's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Dusit Medical Services PCL 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bangkok Dusit Medical Services PCL's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Bangkok Dusit Medical Services PCL's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Bangkok Dusit Medical Services PCL (BDULF) has a 3-Year ROIIC % of 12.83 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Bangkok Dusit Medical Services PCL and its competitors. This is 92% above median its historical median of 6.67. According to the industry distribution chart, Bangkok Dusit Medical Services PCL ranks #206 out of 617 companies in the Healthcare Providers & Services industry, placing it in the top 33.4%.
Is Bangkok Dusit Medical Services PCL's 3-Year ROIIC % too high?
Bangkok Dusit Medical Services PCL's current 3-Year ROIIC % of 12.83 is 92% above median its 10-year median of 6.67. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.46. Bangkok Dusit Medical Services PCL's value of 12.83 is 270.8% above this industry median. Based on the distribution chart, Bangkok Dusit Medical Services PCL ranks #206 out of 617 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Bangkok Dusit Medical Services PCL has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bangkok Dusit Medical Services PCL's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bangkok Dusit Medical Services PCL ranks #206 out of 617 companies for 3-Year ROIIC %. This puts Bangkok Dusit Medical Services PCL in the upper half of its industry. The industry median 3-Year ROIIC % is 3.46. Bangkok Dusit Medical Services PCL's value of 12.83 is 270.8% above this benchmark. While the company's 10-year median is 6.67 vs. the industry median of 3.46, Bangkok Dusit Medical Services PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.46, based on 617 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Dusit Medical Services PCL's current 3-Year ROIIC % of 12.83 is 270.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Bangkok Dusit Medical Services PCL and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Dusit Medical Services PCL's current 3-Year ROIIC % is 12.83, which is 92% above median its own 10-year median of 6.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Dusit Medical Services PCL stock overvalued right now?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL (BDULF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.97, compared to a current price of $0.56 — trading 42.3% below its estimated fair value. The current 3-Year ROIIC % is 12.83, which is 92% above median its 10-year median of 6.67 and 270.8% above the Healthcare Providers & Services industry median of 3.46. Bangkok Dusit Medical Services PCL's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Bangkok Dusit Medical Services PCL (BDULF), the current 3-Year ROIIC % is 12.83 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bangkok Dusit Medical Services PCL (BDULF) Overvalued in 2026?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL stock appears to be undervalued.
The current stock price of $0.56 is trading 42.3% below its estimated GF Value™ of $0.97.
GuruFocus considers Bangkok Dusit Medical Services PCL to be Significantly Undervalued.
Key valuation signals for BDULF:
3-Year ROIIC %: 12.83 (92% above median its 10-year median of 6.67)
GF Value™: $0.97 vs. price of $0.56 (42.3% below fair value)
Industry Position: 270.8% above the Healthcare Providers & Services median (#206 of 617)
No single metric tells the full story. See the BDULF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bangkok Dusit Medical Services PCL Business Description
Bangkok Dusit Medical Services PCL operates a network of private hospitals in Thailand and some overseas markets, under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments, namely hospital operations and other businesses that support hospital business, such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The company's hospital operations generate the vast majority of its revenue.
68GF Score
Get the complete analysis for BDULF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDULF has been successfully added to your 
